Professor and Associate Dean for Research
Administration, Research, Office of Sponsored Research
United States of America
Dr. Alejandro Gugliucci is a founding faculty member at Touro University, California, USA which he joined in 1997. He earned his MD and Board Certification in Laboratory Medicine from the University of the Republic, Uruguay. He obtained his PhD in Biochemistry at the University Louis Pasteur of Strasbourg, France. His postdoctoral fellowship in Cell Biology was carried out at the University of Montreal, Canada, where he also worked a few years as a faculty member before moving to the USA. In his alma mater he was a professor in the Biochemistry and Clinical Pathology departments where he was Head of the Lipoprotein Metabolism division at 20-floor, 800 bed hospital for more than 10 years. He was a visiting professor in Tokyo Juntendo University and Niigata Medical School, Japan in 1998 and at the University of Sao Paulo, Brazil in 2007. He has been Full Professor of Biochemistry for the past 8 years. He served as COM Research Director then Associate Dean for Research for the past 10 years leading the exponential growth of research at TUC, the most significant in the Touro College system. He has been recently appointed as University Director of Research Development and Sponsored Programs.
Role of glycation, oxidative reactions and the antioxidant enzyme paraoxonase on human disease, with a particular emphasis in diabetes, metabolic syndrome, obesity and atherosclerosis.
Influence of ezetimibe monotherapy on ischemia-modified albumin levels in hypercholesterolemic patients. Pharmacological reports : PR 2011; 63:1248-1251.
Association between reactive oxygen metabolites and paraoxonase 1 activity during a physical activity increase intervention with older Japanese people. Australasian journal on ageing 2012; 31:222-226.
Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function. Clinica chimica acta; international journal of clinical chemistry 2013; 415:162-168.
Circulating soluble RAGE increase after a cerebrovascular event. Clinical chemistry and laboratory medicine : CCLM / FESCC 2013:1-8.